|
|
|
| Study of Changes of Plasma D-dimer and Lipoprotein(a) during Intravenous Thrombolysis with rt-PA in Patients with Acute Cerebral Infarction |
| FAN Jingfeng |
| Dalian Friendship Hospital, Liaoning Dalian 116001, China |
|
|
|
|
Abstract Objective: To explore the changes and significance of plasma D-dimer and lipoprotein(a) in the process of intravenous thrombolysis with rt-PA in acute cerebral infarction. Methods: The plasma D-dimer and lipoprotein(a) were dynamically monitored by the technique of immunofluorescence and biochemical analysis before thrombolysis and 1, 2, 24 h after intravenous thrombolysis in patients with cerebral infarction. Results: Plasma D- dimer and lipoprotein (a) increased significantly after 1 hours and 2 hours after intravenous thrombolysis, while the levels of rt-PA decreased rapidly 24 hours after intravenous thrombolysis, but still higher than that before intravenous thrombolysis. Conclusions: After cerebral infarction, after intravenous thrombolysis, plasma D- dimer level and lipoprotein (a) level all show a concordance, which first increased and then decreased. It indicates that there is a certain change in coagulation, fibrinolytic system and lipid metabolism after cerebral venous thrombolysis in rt-PA. This change trend is of certain significance for guiding and judging intravenous thrombolysis.
|
|
|
|
|
|
[1] Zlatohlavek L, Zidkova K, Vrablik M, et al. Lipoprotein(a) and its position among other risk factors of atherosderosis[J].Physiol Res, 2008, 57: 777~783.
[2] Chakraborty B, Vishnoi G, Goswami B, et al. Lipoprotein(a), Ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in north indian patients[J].Stroke Cerebrovasc Dis, 2013, 22(7): e159~e167.
[3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246~255.
[4] 高晶,郭玉璞,谭静江,等.组织学方法界定脑梗死缺血半暗带的可行性探讨[J].中华神经科杂志,2001,34(2):99~102.
[5] Lowe GD. How to search for the role and prevalence of defective fibrinolytic states as triggers of myocardial infarction. The haemostasis epidemiologist's view[J]. Ital Heart,2001, 9: 656~657.
[6] 赵旭兰,张世阳,赵会颖等.老年急性冠状动脉综合征患者血清胆红素、脂蛋白(a)水平及其冠状动脉病变严重程度关系[J].中国循坏杂志,2010,25(4):267~269.
[7] Haapaniemi E, Soinne L, Syijala M, et al. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke[J].Acta Neural Scand, 2004, 110: 242~247.
[8] Khera AV, Everett BM, Caulfield MP, et al. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk:an analysis from the JUPITER Trial (Justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)[J].Circulation, 2014,129: 635.
[9] Hoover Plow J, Huang M. Lipoprotein(a) metabolism: potential sites for therapeutic targets[J].Metabolism, 2013, 62: 479~491. |
|
|
|
2018, Vol. 24 
